Article Dans Une Revue Emerging Infectious Diseases Année : 2023

Multicenter Retrospective Study of Vascular Infections and Endocarditis Caused by Campylobacter spp., France

1 CHU Bordeaux - Centre Hospitalier Universitaire de Bordeaux
2 HCL - Hospices Civils de Lyon
3 INSERM - Institut National de la Santé et de la Recherche Médicale
4 CHU Toulouse - Centre Hospitalier Universitaire de Toulouse
5 CHU Dijon - Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand
6 CHU Angers - Centre Hospitalier Universitaire d'Angers
7 Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]
8 CHU - BREST - Hopital de Bohars - CHRU Brest
9 CHU Caen Normandie - CHU Caen Normandie – Centre Hospitalier Universitaire de Caen Normandie
10 HEGP - Hôpital Européen Georges Pompidou [APHP]
11 CHU Nantes - Centre Hospitalier Universitaire de Nantes = Nantes University Hospital
12 CHU Limoges
13 CHRU Besançon - Centre Hospitalier Régional Universitaire de Besançon
14 Centre Hospitalier de Bigorre [Tarbes]
15 Centre Hopitalier Pierre Oudot [Bourgoin-Jallieu]
16 CHD Vendée - Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon
17 CHU Nancy - Centre Hospitalier Universitaire de Nancy
18 CHU de Poitiers [La Milétrie] - Centre hospitalier universitaire de Poitiers = Poitiers University Hospital
19 PHAR2 [Poitiers] - Pharmacologie des anti-infectieux et antibiorésistance [U 1070]
20 UFR Santé [Poitiers] - Université de Poitiers – UFR Santé [Faculté de Médecine et de Pharmacie]
21 Centre Hospitalier Rodez
22 CH Saint-Brieuc - Centre hospitalier de Saint-Brieuc [Hôpital Yves Le Foll]
23 CHRU Tours - Centre Hospitalier Régional Universitaire de Tours
24 Hôpital Necker - Enfants Malades [AP-HP]
25 Imperial College London
Cyrielle Codde
  • Fonction : Auteur

Résumé

The incidence of campylobacteriosis has substantially increased over the past decade, notably in France. Secondary localizations complicating invasive infections are poorly described. We aimed to describe vascular infection or endocarditis caused by Campylobacter spp. We included 57 patients from a nationwide 5-year retrospective study on Campylobacter spp. bacteremia conducted in France; 44 patients had vascular infections, 12 had endocarditis, and 1 had both conditions. Campylobacter fetus was the most frequently involved species (83%). Antibiotic treatment involved a β-lactam monotherapy (54%) or was combined with a fluoroquinolone or an aminoglycoside (44%). The mortality rate was 25%. Relapse occurred in 8% of cases and was associated with delayed initiation of an efficient antimicrobial therapy after the first symptoms, diabetes, and coexistence of an osteoarticular location. Cardiovascular Campylobacter spp. infections are associated with a high mortality rate. Systematically searching for those localizations in cases of C. fetus bacteremia may be warranted.

Fichier principal
Vignette du fichier
22-1417-1.pdf (699.82 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04132739 , version 1 (31-10-2023)
hal-04132739 , version 2 (24-05-2024)

Licence

Identifiants

Citer

Claire Tinévez, Philippe Lehours, Anne-Gaëlle Ranc, Yaniss Belaroussi, Charles Cazanave, et al.. Multicenter Retrospective Study of Vascular Infections and Endocarditis Caused by Campylobacter spp., France. Emerging Infectious Diseases, 2023, 29 (3), pp.484-492. ⟨10.3201/eid2903.221417⟩. ⟨hal-04132739v2⟩
449 Consultations
298 Téléchargements

Altmetric

Partager

  • More